
MVM Partners leads $62m round for SkyCell
MVM Partners has led a $62m growth funding round for Switzerland-based pharmaceutical containers manufacturer SkyCell, with participation from existing investors Swiss Entrepreneurs Fund and BCGE Bank's growth fund.
The round was also backed by a consortium of Switzerland-based family offices and a Swiss insurance company.
SkyCell plans to use the fresh capital to expand internationally, with a focus on the US and Asia.
MVM is currently deploying equity from MVM Fund V, which held a final close in November 2018 on £150m. The fund deploys equity tickets of $15-30m and focuses on life sciences and pharmaceutical businesses.
Company
SkyCell produces temperature-controlled air freight containers that use Internet-of-Things technology for use in logistics in the pharmaceuticals industry. It delivers 22,000 pallets per year, according to its website.
The company was founded in 2013 and is based in Zürich. It has 59 employees, according to LinkedIn. The company generates revenues of $2m, according to Zoominfo.
People
SkyCell – Richard Ettl (CEO, co-founder).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater